Nanoviricides, Inc.
NNVC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001379006
No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Nanoviricides, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −2 vs. Q1 2022
- Shares held
- 1.11M
- −54.9K (−4.7%) vs. Q1 2022
- Total value
- $2.09M
- −$353.7K (−14.5%) vs. Q1 2022
- New holders
- 2
- 4 more added
- Sold out
- 4
- 7 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NNVC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $3.27M |
| Q1 2026 | 48 | $1.73M |
| Q4 2025 | 43 | $3.51M |
| Q3 2025 | 35 | $2.04M |
| Q2 2025 | 33 | $1.87M |
| Q1 2025 | 37 | $1.74M |
| Q4 2024 | 36 | $2.09M |
| Q3 2024 | 32 | $2.01M |
| Q2 2024 | 34 | $2.31M |
| Q1 2024 | 29 | $1.38M |
| Q4 2023 | 32 | $1.24M |
| Q3 2023 | 30 | $1.61M |
| Q2 2023 | 27 | $1.42M |
| Q1 2023 | 31 | $1.47M |
| Q4 2022 | 30 | $1.51M |
| Q3 2022 | 31 | $2.30M |
| Q2 2022 | 25 | $2.09M |
| Q1 2022 | 27 | $2.45M |
| Q4 2021 | 29 | $4.13M |
| Q3 2021 | 33 | $4.44M |
| Q2 2021 | 28 | $4.22M |
| Q1 2021 | 34 | $4.68M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Nanoviricides, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 123 | $0 | 0.00% | −637−83.8% | Reduced |
| US Bancorp | 50 | $0 | 0.00% | +7+16.3% | Added |
| Bank of America Corp | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 270 | $0 | 0.00% | +50+22.7% | Added |
| Tfo-TDC, LLC | 65 | $0 | 0.00% | 00.0% | Unchanged |
| Prospera Financial Services Inc | 450 | $1.00K | 0.00% | 00.0% | Unchanged |
| Clearstead Advisors, LLC | 293 | $1.00K | 0.00% | +293 | New |
| TD Waterhouse Canada Inc. | 429 | $1.03K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 1,100 | $2.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1,000 | $2.00K | 0.00% | +1,000 | New |
| Wells Fargo & Company | 2,120 | $4.00K | 0.00% | −2,951−58.2% | Reduced |
| Tower Research Capital LLC (TRC) | 2,251 | $4.00K | 0.00% | −1,698−43.0% | Reduced |
| Federation des caisses Desjardins du Quebec | 3,010 | $5.66K | 0.00% | 00.0% | Unchanged |
| First Financial Bank - Trust Division | 10,881 | $20.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 11,237 | $21.0K | 0.00% | −6,211−35.6% | Reduced |
| Wharton Business Group, LLC | 17,236 | $32.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 18,494 | $35.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 41,906 | $79.0K | 0.00% | +1,400+3.5% | Added |
| Renaissance Technologies LLC | 60,000 | $113.0K | 0.00% | −16,800−21.9% | Reduced |
| Bridgeway Capital Management, LLC | 94,039 | $177.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 110,100 | $206.0K | 0.00% | +1,600+1.5% | Added |
| Compagnie Lombard Odier SCmA | 150,000 | $282.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 160,948 | $302.0K | 0.00% | −28,548−15.1% | Reduced |
| Vanguard Group Inc | 427,878 | $804.0K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 21 | – | – | −28−57.1% | Reduced |
| Alaethes Wealth LLC | 0 | $0 | 0.00% | −2,133−100.0% | Sold out |
| Sandy Spring Bank | 0 | $0 | 0.00% | −265−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −1−100.0% | Sold out |